We are live on ! Find out more
DMK

DMK Pharmaceuticals Corporation Common Stock
DMK

Delisted

DMK was delisted on the 6th of February, 2024.

Back to rankings

3 hedge funds and large institutions have $4 invested in DMK Pharmaceuticals Corporation Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% less funds holding

Funds holding: 29 → 3 (-26)

96% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 27

100% less capital invested

Capital invested by funds: $351K → $4 (-$351K)

Holders
3
Holders Change
-26
Holders Change %
-89.66%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
27
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
OPTFSNA
Old Point Trust & Financial Services N A
Virginia
+$8

Top Sellers

Rank Fund Capital Flow
1
JP Morgan Chase
JP Morgan Chase
New York
-$74.4K
2
Northern Trust
Northern Trust
Illinois
-$72.5K
3
Geode Capital Management
Geode Capital Management
Massachusetts
-$49.8K
4
TRCT
Tower Research Capital (TRC)
New York
-$45.6K
5
BlackRock
BlackRock
New York
-$27.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPA
1
Clear Point Advisors
New York
$3 – – –
OPTFSNA
2
Old Point Trust & Financial Services N A
Virginia
$1 +$8 +14 New
JP Morgan Chase
3
JP Morgan Chase
New York
– -$74.4K -106,209 Closed
Northern Trust
4
Northern Trust
Illinois
– -$72.5K -103,493 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
– -$49.8K -71,098 Closed
TRCT
6
Tower Research Capital (TRC)
New York
– -$45.6K -65,203 Closed
BlackRock
7
BlackRock
New York
– -$27.1K -38,735 Closed
Vanguard Group
8
Vanguard Group
Pennsylvania
– -$23.8K -33,990 Closed
VF
9
Virtu Financial
New York
– -$16K -22,185 Closed
Susquehanna International Group
10
Susquehanna International Group
Pennsylvania
– -$14.2K -20,237 Closed
TSS
11
Two Sigma Securities
New York
– -$12.6K -18,059 Closed
HF
12
HRT Financial
New York
– -$11K -16,558 Closed
Morgan Stanley
13
Morgan Stanley
New York
– -$1.87K -2,670 Closed
UBS Group
14
UBS Group
Switzerland
– -$1.09K -1,562 Closed
Bank of America
15
Bank of America
North Carolina
– -$392 -561 Closed
LPP
16
Life Planning Partners
Florida
– -$213 -304 Closed
Wells Fargo
17
Wells Fargo
California
– -$149 -214 Closed
HI
18
Harbour Investments
Wisconsin
– -$128 -183 Closed
WWM
19
Wolff Wiese Magana
California
– -$102 -145 Closed
Group One Trading
20
Group One Trading
Illinois
– -$66 -94 Closed
Osaic Holdings
21
Osaic Holdings
Arizona
– -$61 -87 Closed
ASN
22
Advisory Services Network
Georgia
– -$50 -71 Closed
AF
23
Allworth Financial
California
– -$36 -50 Closed
NA
24
NewEdge Advisors
Louisiana
– -$27 -38 Closed
HCM
25
Hollencrest Capital Management
California
– -$20 -28 Closed
1
2

DMK Hedge Fund Activity: Q1 2024 in Review

3 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q1 2024, worth a combined $4 — down 100% from $351K a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of DMK and 1 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was Old Point Trust & Financial Services N A, opening a new position worth an estimated $8. The largest seller was JP Morgan Chase, exiting entirely with an estimated $74.4K sold.

  • 3 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q1 2024, down from 29 in Q4 2023.
  • Funds reported $4 of DMK Pharmaceuticals Corporation Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 1 fund opened new DMK Pharmaceuticals Corporation Common Stock positions in Q1 2024 and 27 closed out, a net change of -26 holders.
  • The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q1 2024 was Old Point Trust & Financial Services N A, an estimated $8 added.
  • The largest DMK Pharmaceuticals Corporation Common Stock seller in Q1 2024 was JP Morgan Chase, an estimated $74.4K sold.

Based on aggregated 13F filings for Q1 2024.